1. Home
  2. Vol 4, No 2 (2019)
  3. Wicaksono

ANALYSIS OF TRENDS IN THE AVAILABILITY OF INDICATOR DRUGS AND VACCINES IN PUBLIC HEALTH CENTER FOR 2016-2017

Aji Wicaksono, Kemal N. Siregar

Abstract


ABSTRACTThe health development strategies for 2015-2019 is about improving the availability, affordability, equity and quality of pharmaceuticals and medical devices. Since the enactment of national health insurance (JKN) on January 1, 2014, the availability of drug at the public health center become a very important aspect in primary health care services. Drug logistics management is an important aspect that influences accessibility to health services including the availability of essential drugs and vaccines. The aim of this study is to explore the trend of availability indicator drugs and vaccines in public health center for the period of 2016-2017 and drug logistics management factors that can affect the availability. The study was conducted using secondary data analysis. Data were obtained from data on the availability of indicator drugs and vaccines in public health center for the period of 2016-2017. This research is a quantitative study with an analytical observational approach. The Vector Auto Regression(VAR) conducted provides forecasting trends in indicator drugs and vaccines in public health center close to 80%. The 80% figure shows appropriate availability, but there are a number of things that need special attention including planning, procurement, pharmaceutical competency, financing, and management information systems.ABSTRAK Strategi pembangunan kesehatan tahun 2015-2019 antara lain meningkatkan ketersediaan, keterjangkauan, pemerataan, dan kualitas farmasi dan alat kesehatan. Sejak diberlakukannya Jaminan Kesehatan nasional (JKN) pada 1 Januari 2014, ketersediaan obat di puskesmas merupakan aspek yang sangat penting dalam pelayanan kesehatan di Fasilitas Kesehatan Tingkat Pertama (FKTP). Pengelolaan obat di puskesmas haruslah baik dan benar, karena pengelolaan yang baik dan benar akan menjamin ketersediaan obat sesuai dengan kebutuhan puskesmas. Penelitian ini ingin melihat trend ketersediaan obat dan vaksin indikator di puskesmas periode tahun 2016-2017. Studi dilakukan dengan menggunakan analisis data sekunder. Data didapatkan dari data ketersediaan obat dan vaksin esensial di puskesmas periode tahun 2016-2017. Pendekatan Vector Auto Regression (VAR) yang dilakukan memberikan peramalan trend obat dan vaksin indikator di puskesmas mendekati angka kurang lebih 80%. Angka tersebut menunjukkan ketersediaan yang sesuai tetapi ada sejumlah hal yang perlu mendapat perhatian khusus antara lain peran dan kompetensi tenaga kefarmasian dalam menjamin ketersediaan obat, dana kapitasi untuk pembelanjaan obat di puskesmas, perencanaan kebutuhan obat, dan pencatatan dan pelaporan di puskesmas.

Keywords


availability of indicator drugs and vaccines; public health center; trends

Full Text:

PDF

References


United Nations. Sustainable Development Goal 3 Ensure healthy lives and promote well-being for all at all ages [Internet]. 2015 [cited 2018 Apr 3]. Available from: https://sustainabledevelopment.un.org/sdg3

Embrey M, Ryan M, Glassman L, Dukes G. MDS-3: Managing access to medicines and health technologies. Management sciences for health. Virginia: Management Sciences for Health, Inc. All; 2012. p. Chapter 9.

Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: A secondary analysis. Lancet [Internet]. 2009;373. Available from: http://dx.doi.org/10.1016/S0140-6736(08)61762-6

World Health Organization Regional Office for South East Asia. Improving access to medicines in the South-East Asia region progress, challenges, priorities. 2017;

MacLennan CA. Vaccines for low-income countries. Semin Immunol [Internet]. 2013;25(2):114–23. Available from: http://dx.doi.org/10.1016/j.smim.2013.05.004

World Health Organization. The selection and use of essential medicines. Rep WHO Expert Committee, 2002 (including 12th Model List Essent Med [Internet]. 2003 [cited 2018 Apr 17]; Available from: http://apps.who.int/medicinedocs/pdf/s4875e/s4875e.pdf

Kementerian Kesehatan RI. Rencana strategis Kementerian Kesehatan tahun 2015-2019 revisi I. 2017;1.

Direktorat Jenderal Kefarmasian dan Alat Kesehatan KKR. Petunjuk teknis tata kelola indikator kinerja tata kelola obat publik dan perbekalan kesehatan tahun 2017-2019. 2017;I.

World Health Organization. WHO medicines strategy: framework for action essential drugs and medicines policy 2000–2003. 2000; Available from: http://apps.who.int/medicinedocs/pdf/whozip16e/whozip16e.pdf

Bazargani YT, Ewen M, Boer A De, Leufkens HGM, Mantel-teeuwisse AK. Essential Medicines Are More Available than Other Medicines around the Globe. 2014;9(2):1–7.

Gauthfa A, Kuswinarti K, Sunjaya D. Dampak implementasi jaminan kesehatan nasional terhadap ketersediaan obat di apotek rujukan wilayah Cibeunying kotamadya Bandung tahun 2015. J Sist Kesehat [Internet]. 2016;1(4):159–64. Available from: http://journal.unpad.ac.id/jsk_ikm/article/view/10374/4736

Departemen Kesehatan Republik Indonesia. Pedoman Pengelolaan Obat Publik dan Perbekalan Kesehatan. 2002.

Rahem A. Profil pengelolaan dan ketersediaan obat anti diabetes oral di puskesmas. 2017;4(2):75–80.

Hasan AG, Adisasmito WBB. Analisis kebijakan pemanfaatan dana kapitasi JKN pada FKTP puskesmas di kabupaten Bogor tahun 2016. 2017;6(03):127–37.

Boyangan G, Tumurang MN, Raule JH. Analisis Pelaksanaan Rujukan Peserta JKN dari Fasilitas Kesehatan Tingkat I di Puskesmas Bahu Kota Manado. 2015;

Kementerian Kesehehatan RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 74 Tahun 2016 tentang standar pelayanan kefarmasian di puskesmas. 2016.

Carolien I, Fudholi A, Endarti D. Evaluasi Ketersediaan Obat Sebelum dan Sesudah Implementasi JKN pada Puskesmas di Kabupaten Keerom Provinsi Papua. J Manaj dan Pelayanan Farm. 2017;7(1):30–9.

Sanjaya GY, Hidayat AW. Pemantauan obat dan perbekalan kesehatan di Indonesia : tantangan dan pengembangannya. 2016;159–68.




DOI: http://dx.doi.org/10.7454/ihpa.v4i2.3102

Refbacks

  • There are currently no refbacks.